Drug policy 101: Drug patents

As drug prices continue rising unsustainably in the United States, patients and payers need to understand — and policy makers…

Drug policy 101: Biosimilars

Biologics — drugs derived from living organisms that are used to treat conditions such as rheumatoid arthritis, multiple sclerosis, and…